148 related articles for article (PubMed ID: 22320154)
21. The interaction of amphiregulin with nuclei and putative nuclear localization sequence binding proteins.
Modrell B; McDonald VL; Shoyab M
Growth Factors; 1992; 7(4):305-14. PubMed ID: 1306686
[TBL] [Abstract][Full Text] [Related]
22. Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth.
Inui S; Higashiyama S; Hashimoto K; Higashiyama M; Yoshikawa K; Taniguchi N
J Cell Physiol; 1997 Jun; 171(3):291-8. PubMed ID: 9180898
[TBL] [Abstract][Full Text] [Related]
23. Validation of HB-EGF and amphiregulin as targets for human cancer therapy.
Yotsumoto F; Yagi H; Suzuki SO; Oki E; Tsujioka H; Hachisuga T; Sonoda K; Kawarabayashi T; Mekada E; Miyamoto S
Biochem Biophys Res Commun; 2008 Jan; 365(3):555-61. PubMed ID: 18023415
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism.
Berasain C; Nicou A; Garcia-Irigoyen O; Latasa MU; Urtasun R; Elizalde M; Salis F; Perugorría MJ; Prieto J; Recio JA; Corrales FJ; Avila MA
Dig Dis; 2012; 30(5):524-31. PubMed ID: 23108309
[TBL] [Abstract][Full Text] [Related]
25. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells.
Gschwind A; Hart S; Fischer OM; Ullrich A
EMBO J; 2003 May; 22(10):2411-21. PubMed ID: 12743035
[TBL] [Abstract][Full Text] [Related]
26. Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Chang W; Guan W; Liu Y; Shen Q; Yu Y; Zhang H; Cao G
Cancer; 2013 Oct; 119(19):3436-45. PubMed ID: 23821160
[TBL] [Abstract][Full Text] [Related]
27. Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells.
Gilmore JL; Scott JA; Bouizar Z; Robling A; Pitfield SE; Riese DJ; Foley J
Breast Cancer Res Treat; 2008 Aug; 110(3):493-505. PubMed ID: 17882547
[TBL] [Abstract][Full Text] [Related]
28. TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin.
Yang N; Morrison CD; Liu P; Miecznikowski J; Bshara W; Han S; Zhu Q; Omilian AR; Li X; Zhang J
Cell Cycle; 2012 Aug; 11(15):2922-30. PubMed ID: 22825057
[TBL] [Abstract][Full Text] [Related]
29. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells.
Castillo J; Erroba E; Perugorría MJ; Santamaría M; Lee DC; Prieto J; Avila MA; Berasain C
Cancer Res; 2006 Jun; 66(12):6129-38. PubMed ID: 16778186
[TBL] [Abstract][Full Text] [Related]
30. ADAM-mediated amphiregulin shedding and EGFR transactivation.
Kasina S; Scherle PA; Hall CL; Macoska JA
Cell Prolif; 2009 Dec; 42(6):799-812. PubMed ID: 19735466
[TBL] [Abstract][Full Text] [Related]
31. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
32. Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy.
Funatomi H; Itakura J; Ishiwata T; Pastan I; Thompson SA; Johnson GR; Korc M
Int J Cancer; 1997 Jul; 72(3):512-7. PubMed ID: 9247297
[TBL] [Abstract][Full Text] [Related]
33. Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer.
Regales L; Gong Y; Shen R; de Stanchina E; Vivanco I; Goel A; Koutcher JA; Spassova M; Ouerfelli O; Mellinghoff IK; Zakowski MF; Politi KA; Pao W
J Clin Invest; 2009 Oct; 119(10):3000-10. PubMed ID: 19759520
[TBL] [Abstract][Full Text] [Related]
34. Cell surface annexins regulate ADAM-mediated ectodomain shedding of proamphiregulin.
Nakayama H; Fukuda S; Inoue H; Nishida-Fukuda H; Shirakata Y; Hashimoto K; Higashiyama S
Mol Biol Cell; 2012 May; 23(10):1964-75. PubMed ID: 22438584
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma.
Hurbin A; Wislez M; Busser B; Antoine M; Tenaud C; Rabbe N; Dufort S; de Fraipont F; Moro-Sibilot D; Cadranel J; Coll JL; Brambilla E
J Pathol; 2011 Sep; 225(1):83-95. PubMed ID: 21598249
[TBL] [Abstract][Full Text] [Related]
36. Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance Induced by Membranous/Cytoplasmic/Nuclear Translocation of Epidermal Growth Factor Receptor.
Rong X; Liang Y; Han Q; Zhao Y; Jiang G; Zhang X; Lin X; Liu Y; Zhang Y; Han X; Zhang M; Luo Y; Li P; Wei L; Yan T; Wang E
J Thorac Oncol; 2019 Oct; 14(10):1766-1783. PubMed ID: 31228625
[TBL] [Abstract][Full Text] [Related]
37. Expression of amphiregulin, a novel gene of the epidermal growth factor family, in human gastric carcinomas.
Kitadai Y; Yasui W; Yokozaki H; Kuniyasu H; Ayhan A; Haruma K; Kajiyama G; Johnson GR; Tahara E
Jpn J Cancer Res; 1993 Aug; 84(8):879-84. PubMed ID: 8407551
[TBL] [Abstract][Full Text] [Related]
38. Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors.
Chang MH; Ahn HK; Lee J; Jung CK; Choi YL; Park YH; Ahn JS; Park K; Ahn MJ
Cancer; 2011 Jan; 117(1):143-51. PubMed ID: 20803614
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor ligands as new extracellular targets for the metastasis-promoting S100A4 protein.
Klingelhöfer J; Møller HD; Sumer EU; Berg CH; Poulsen M; Kiryushko D; Soroka V; Ambartsumian N; Grigorian M; Lukanidin EM
FEBS J; 2009 Oct; 276(20):5936-48. PubMed ID: 19740107
[TBL] [Abstract][Full Text] [Related]
40. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling.
Wong L; Deb TB; Thompson SA; Wells A; Johnson GR
J Biol Chem; 1999 Mar; 274(13):8900-9. PubMed ID: 10085134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
